[ Price : $8.95]
Decision Resources projects modest sales growth for antidepressants in the next decade because of patent expirations in several le...[ Price : $8.95]
Neopharm Inc. says a pivotal Phase 3 trial involving an experimental cancer drug failed to meet its efficacy endpoint.[ Price : $8.95]
Researchers say doctors respond better to general requests for antidepressant medications rather than to requests for specific dru...[ Price : $8.95]
New Zealands government backs away from restricting drug DTC ads.[ Price : $8.95]
FDA deputy commissioner for medical and scientific affairs Scott Gottlieb resigns his post at the agency to return to the conserva...[ Price : $8.95]
A federal appeals court judge keeps in place an injunction preventing Apotex from marketing its generic Plavix until a patent disp...[ Price : $8.95]
FDA says proposed rules on access to and charging for experimental drugs used in treatment should eliminate confusion that has exi...[ Price : $8.95]
FDA classifies as Class 1 two earlier recalls involving counterfeit blood glucose test strips used in LifeScans One Touch monitor....